✦ LIBER ✦
Increased survival associated with radiolabeled lym-1 therapy for non-hodgkin's lymphoma and chronic lymphocytic leukemia
✍ Scribed by Gerald L. DeNardo; Kathleen R. Lamborn; Desirée S. Goldstein; Linda A. Kroger; Sally J. DeNardo
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 162 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
on baseline Karnofsky performance status (KPS) and serum lactic dehydrogenase California.
(LDH) predicted response and survival and was used to define risk groups. Propor-2 Brain Tumor Research Center, Department of tional-hazards, Kaplan-Meier, and Landmark models were used to evaluate pa-Neurological Surgery, University of California rameters for their ability to predict outcome.